Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases

Experimental Dermatology

Volumn 13, Issue 1, 2004, Pages 27-32

  Becker, Bernd ^a   Multhoff, G ^a   Farkas, B ^b   Wild, P J ^a   Landthaler, M ^a   Stolz, W ^a   Vogt, T ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Medical University of Pécs   (Germany)

Author keywords

Heat shock protein 90; Hsp90; Immunotherapy; Melanoma

Indexed keywords

HEAT SHOCK PROTEIN 90; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CELL FUNCTION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; MICRODISSECTION; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS;

BIOPSY; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0842329639     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2004.00114.x     Document Type: Article

References (35)

1. Hartson S D, Matts R L. Association of Hsp90 with cellular Src-family kinases in a cell-free system correlates with altered kinase structure and function. Biochemistry 1994: 33: 8912-8920.
2. Hartson S D, Barett D J, Burn P, Matts R L. Hsp90-mediated folding of the lymphoid cell kinase p561ck. Biochemistry 1996: 35: 13451-13459.
3. Schulte T W, Blagosklonny M V, Ingui C, Neckers L. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association. J Biol Chem 1995: 270: 24585-24588.
4. Helmbrecht K, Zeise E, Rensing L. Chaperones in cell cycle regulation and mitogenic signal transduction: A review. Cell Prolif 2000: 33: 341-365.
5. Dittmar K D, Pratt W B. Folding of the glucocorticoid receptor by the reconstituted Hsp90-based chaperone machinery. The initial hsp90, p60, hsp70-dependent step is sufficient for creating the steroid binding conformation. J Biol Chem 1997: 272: 13047-13054.
6. Denis M, Gustafsson J A. The Mr approximately 90,000 heat-shock protein: An important modulator of ligand and DNA-binding properties of the glucocorticoid receptor. Cancer Res 1989: 49: 2275s-2281s.
7. Holt S E, Aisner D L, Baur J, et al. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev 1999: 13: 817-826.
8. Akalin A, ELmore L W, Forsythe H L, et al. A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression. Cancer Res 2001: 61: 4791-4796.
9. Glaessl A, Bosserhoff A K, Buettner R, Hohenleutner U, Landthaler M, Stolz W. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas. Arch Dermatol Res 1999: 291: 81-87.
10. Rutherford S L, Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature 1998: 396: 336-342.
11. Vogt T, Stolz W, Welsh J, et al. Overexpression of Lerk-5/Eplg5 messenger RNA. A novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Clin Cancer Res 1998: 4: 791-797.
12. Becker B, Vogt T, Landthaler M, Stolz W. Detection of differentially regulated genes in keratinocytes by cDNA array hybridization. Hsp27 and other novel players in response to artificial ultraviolet radiation. J Invest Dermatol 2001: 116: 983-988.
13. Farkas B, Hantschel M, Becker B, et al. Heat-shock protein 70 (Hsp70) membrane expression is associated with a negative Mel-5 phenotype. Melanoma Res 2003: 13: 147-152.
14. Protti M P, Heltai B, Bellone M, Ferrarini M, Manfredi A, Rugardi C. Constitutive expression of the heat-shock protein 72 kDa in human melanoma cells. Cancer Lett 1994: 85: 211-216.
15. Multhoff G, Botzler C, Jennen L, Schmidt J, Ellwart J, Issels R. Heat-shock protein 72 on tumor cells: A recognition structure for natural killer cells. J Immunol 1997: 158: 4341-4350.
16. Multhoff G, Mizzen L, Winchester C C, et al. Heat-shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. Exp Hematol 1999: 27: 1627-1636.
17. Xiao K, Liu W, Qu S, Sun H, Tang J. Study of heat-shock protein HSP90 alpha, HSP70, HSP27 mRNA expression in human acute leukemia cells. J Tongji Med University 1996: 16: 212-216.
18. Nanbu K, Konishi I, Mandai M, et al. Prognostic significance of heat-shock proteins HSP70 and HSP90 in endometrial carcinomas. Cancer Detect Prev 1998: 22: 549-555.
19. Yano M, Naito Z, Yokoyama M, et al. Expression of hsp90 and cyclin D1 in human breast cancer. Cancer Lett 1999: 137: 45-51.
20. Vanmuylder N, Evrard L, Daelemans P, Van Reck J, Dourov N. [Expression of heat-shock protein in salivary gland tumors. Immunohistochemical study of HSP27, HSP70, HSP90, and HSP110: Apropos of 50 cases]. Ann Pathol 2000: 20: 190-195.
21. Yang J, Yang J M, Iannone M, Shih W J, Lin Y, Hait W N. Disruption of the EF-2 kinase/Hsp90 protein complex: A possible mechanism to inhibit glioblastoma by geldanamycin. Cancer Res 2001: 61: 4010-4016.
22. Smith D F, Whitesell L, Katsanis E. Molecular chaperones. Biology and prospects for pharmacological intervention. Pharmacol Rev 1998: 50: 493-514.
23. Pearl Lh, Prodromou C. Structure and in vivo function of Hsp90. Curr Opin Struct Biol 2000: 10: 46-51.
24. Whitesell L, Mimnaugh E G, De Costa B, Myers C E, Neckers L M. Inhibition of heat-shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: Essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci U S A 1994: 91: 8324-8328.
25. Soga S, Kozawa T, Narumi H, et al. Radicicol leads to selective depletion of Raf kinase and disrupts K-Ras-activated aberrant signaling pathway. J Biol Chem 1998: 273: 822-828.
26. Sharma S V, Agatsuma T, Nakano H. Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol. Oncogene 1998: 16: 2639-2645.
27. Queitsch C, Sangster T A, Lindquist S. Hsp90 as a capacitor of phenotypic variation. Nature 2002: 417: 618-624.
28. Piselli P, Vendetti S, Poccia F, et al. In vitro and in vivo efficacy of heat-shock protein specific immunotoxins on human tumor cells. J Biol Regul Homeost Agents 1995: 9: 55-62.
29. Multhoff G, Pfister K, Gehrmann M, et al. A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity. Cell Stress Chaperones 2001: 6: 337-344.
30. Arnold-Schild D, Hanau D, Spehner D, et al. Cutting edge: Receptor-mediated endocytosis of heat-shock proteins by professional antigen-presenting cells. J Immunol 1999: 162: 3757-3760.
31. Schild H, Arnold-Schild D, Lammert E, Rammensee H G. Stress proteins and immunity mediated by cytotoxic T lymphocytes. Curr Opin Immunol 1999: 11: 109-113.
32. Asea A, Kraeft S K, Kurt-Jones E A, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000: 6: 435-442.
33. Srivastava P K, Menoret A, Basu S, Binder R J, McQuade K L. Heat-shock proteins come of age: Primitive functions acquire new roles in an adaptive world. Immunity 1998: 8: 657-665.
34. Binder R J, Harris M L, Menoret A, Srivastava P K. Saturation, competition, and specificity in interaction of heat-shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells. J Immunol 2000: 165: 2582-2587.
35. Binder R J, Han D K, Srivastava P K. CD91: A receptor for heat-shock protein gp96. Nat Immunol 2000: 1: 151-155.